Viridian Therapeutics, Inc./DE Repayments of Related Party Debt
Viridian Therapeutics, Inc./DE (VRDN) reported Repayments of Related Party Debt of $10.46 million for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2015-03-27
- Viridian Therapeutics, Inc./DE repayments of related party debt for the quarter ending 2013-12-31 was $343.00.
- Viridian Therapeutics, Inc./DE repayments of related party debt for the quarter ending 2013-09-30 was $94.47K.
- Viridian Therapeutics, Inc./DE repayments of related party debt for fiscal 2013 was $10.46M.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2013-12-31 | $343.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $94.82K derived: sum of 2 quarters · filed 2015-03-27 | $10.46M 10-K · filed 2015-03-27 | |
| 2013-09-30 | $94.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $10.46M 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $10.37M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |